Honigman Represents Catalio Capital Management as Lead Investor in Evvy’s $40 Million Series B Financing

Honigman recently represented Catalio Capital Management, a health care focused investment firm, as the lead investor in Evvy’s $40 million Series B financing.

Evvy is a women’s health platform that combines diagnostic testing, clinical insights, and care recommendations to help patients better understand and manage their health. The Company serves a broad patient base across the United States and works closely with health care providers.

The Honigman team was led by Corporate Partners Phillip D. Torrence and Rachel Rhodes with support from Associate Aaron Katz.